|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500113842 |
|
最近更新日期: Date of Last Refreshed on: |
2025-12-03 17:21:23 |
|
注册时间: Date of Registration: |
2025-12-03 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
机械吸呼技术联合密闭式吸痰在急性呼吸窘迫综合征有创机械通气患者中的应用效果研究 |
|
Public title: |
Effect of Mechanical Insufflation–Exsufflation Combined with Closed Suction on Patients with Acute Respiratory Distress Syndrome Receiving Invasive Mechanical Ventilation |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
机械吸呼技术联合密闭式吸痰在急性呼吸窘迫综合征有创机械通气患者中的应用效果研究 |
|
Scientific title: |
Effect of Mechanical Insufflation–Exsufflation Combined with Closed Suction on Patients with Acute Respiratory Distress Syndrome Receiving Invasive Mechanical Ventilation |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
丁朋彦 |
研究负责人: |
丁朋彦 |
|
Applicant: |
Ding Pengyan |
Study leader: |
Ding Pengyan |
|
申请注册联系人电话: Applicant telephone: |
+86 155 1185 0797 |
研究负责人电话: Study leader's telephone: |
+86 155 1185 0797 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
574117061@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
574117061@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
河北省石家庄市和平西路348号 |
研究负责人通讯地址: |
河北省石家庄市和平西路348号 |
|
Applicant address: |
348 West Heping Road, Shijiazhuang, Hebei Province, China |
Study leader's address: |
348 West Heping Road, Shijiazhuang, Hebei Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
华北理工大学 |
||
|
Applicant's institution: |
North China University of Science and Technology |
||
|
研究负责人所在单位: |
河北省人民医院 |
||
|
Affiliation of the Leader: |
Hebei General Hospital |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
(2025)科研论审第(459)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
河北省人民医院临床科研项目伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Hebei General Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-08-19 00:00:00 |
||
|
伦理委员会联系人: |
鲁杨 |
||
|
Contact Name of the ethic committee: |
Lu Yang |
||
|
伦理委员会联系地址: |
河北省石家庄市和平西路348号 |
||
|
Contact Address of the ethic committee: |
348 West Heping Road, Shijiazhuang, Hebei Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 311 8598 8311 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
河北省人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Hebei General Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
河北省石家庄市和平西路348号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
348 West Heping Road, Shijiazhuang, Hebei Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
无 |
||||||||||||||||||||||
|
Source(s) of funding: |
N/A |
||||||||||||||||||||||
|
Target disease: |
Acute Respiratory Distress Syndrome |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
MI-E联合密闭式吸痰是否可以更有效清除ARDS机械通气患者气道分泌物,改善气体交换,纠正低氧血症;改善呼吸力学指标;降低炎症指标,减少机械通气时间,及缩短ICU停留时间,改善病人预后。 |
||||||||||||||||||||||
|
Objectives of Study: |
To investigate whether mechanical insufflation-exsufflation (MI-E) combined with closed suctioning can more effectively remove airway secretions in patients with acute respiratory distress syndrome (ARDS), improve gas exchange, correct hypoxemia, reduce inflammatory markers, shorten the duration of mechanical ventilation and length of ICU stay, as well as improve patient prognosis. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)年龄≥18周岁; (2)符合2023版ARDS全球新定义诊断标准; (3)预计机械通气时间≥5天; (4)血流动力学相对稳定,90mmHg≤SBP≤160mmHg,50mmHg≤DBP≤110mmHg,HR<130次/min; (5)患者或法定代理人同意参加此项研究。 |
||||||||||||||||||||||
|
Inclusion criteria |
1.Age >= 18 years old; 2. Meet the diagnostic criteria of the new global definition of ARDS in the 2023 edition; 3.The expected duration of mechanical ventilation >= 5 days; 4. Hemodynamic stability: 90 mmHg<= SBP<= 160 mmHg, 50 mmHg<= DBP<= 110 mmHg, and HR < 130 beats/min; 5. The patient or their legal representative consents to participate in this study. |
||||||||||||||||||||||
|
排除标准: |
(1)既往或目前存在大疱性肺气肿、未经引流的气胸或气胸高危人群、纵隔气肿、近期气压伤、气管食管瘘 (2)肺内有活动性出血、咯血; (3)颅内压增高; (4)鼓膜破裂。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. A history of or current presence of bullous emphysema, un drained pneumothorax or populations at high risk of pneumothorax, mediastinal emphysema, recent barotrauma, and tracheoesophageal fistula 2. Active intrapulmonary hemorrhage or hemoptysis; 3. Increased intracranial pressure; 4. Ruptured tympanic membrane. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-08-20 00:00:00至 To 2026-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2025-08-21 00:00:00 至 To 2026-06-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
研究人员通过SPSS软件生成随机数字 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
A random number sequence was generated by the researchers using SPSS software (version 27.0, IBM Corp., Armonk, NY, USA). |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
由于干预的性质,参与者和干预实施者无法实施盲法;但数据分析人员在统计分析前对组别信息保持盲法。 |
|
Blinding: |
Due to the nature of MI-E interventions, participants and instructors could not be blinded; however, statisticians responsible for data analysis were blinded to group allocation until after the completion of statistical tests. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
N/A |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
研究数据采集采用纸质病例记录表(CRF),由经过培训的研究助理填写;随后由两名独立研究人员录入并核对至电子数据采集系统(EDC),以确保数据的完整性与准确性。研究过程中将定期进行质控与数据备份。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data were collected using paper-based Case Report Forms (CRFs), completed by trained research assistants. The data were then double-entered and cross-checked by two independent researchers into an Electronic Data Capture (EDC) system to ensure accuracy and integrity. Quality control and data backup were performed regularly during the study. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |